Loading clinical trials...
Loading clinical trials...
This study will evaluate the potential of RO4607381 to reduce cardiovascular morbidity and mortality in stable coronary heart disease patients with recent Acute Coronary Syndrome (ACS) and evaluate th...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Hoffmann-La Roche
NCT07493603 · Coronary Heart Disease, Coronary Artery Disease, and more
NCT07451873 · Coronary Heart Disease
NCT06216847 · Coronary Heart Disease (CHD)
NCT07149688 · Atrial Fibrillation (AF), Hypertension, and more
NCT06759805 · Coronary Artery Disease, Cardiac Rehabilitation, and more
Birmingham, Alabama
Birmingham, Alabama
Birmingham, Alabama
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions